secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023427
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Pathways Q1 net loss $17.9M; cash $260.1M; phase 3 top-line data expected late June
--------------------------------------------------------------------------------

- Net loss $17.9M ($0.24 diluted EPS) vs $35.2M ($0.55) in Q1 2024; includes $19.5M non-cash gain on warrant liabilities.
- R&D expenses $30.9M, up 24% YoY due to advancing COMP360 phase 3 trials; G&A $18.7M, up 36%.
- Cash $260.1M at Mar 31, 2025, vs $165.1M at Dec 31, 2024; net cash raised $140.4M in Q1.
- Top-line 6-week data from COMP005 phase 3 in TRD expected late June 2025; COMP006 26-week data H2 2026.
- Full-year 2025 net cash used in ops guided at $120M-$145M; cash expected to fund through COMP006 readout.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000162828025023427/0001628280-25-023427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000162828025023427/cmps-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer